Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Bladder Cancer

Free Subscription 04.10.2021 1 APMIS 1 Biomedicines 1 Biomolecules 1 BMC Urol 1 BMJ Open 3 Br J Cancer 1 Can Urol Assoc J 1 Cancer Invest 1 Cancer Radiother 3 Cancers (Basel) 1 Cir Cir 1 Clin Transl Med 1 Comput Biol Med 1 Cureus 1 Eur J Cancer 1 Eur Urol Focus 2 Exp Ther Med 1 Front Cell Dev Biol 1 Front Genet 2 Front Oncol 1 Hum Exp Toxicol 1 Int J Hyperthermia 1 Int J Mol Sci 1 Int Urol Nephrol 1 J Basic Clin Physiol Pharmacol 3 J BUON 1 J Clin Med 1 J Cutan Pathol 1 J Manag Care Spec Pharm 1 J Med Case Rep 1 J Pers Med 1 J Urol 1 Medicina (Kaunas) 1 Metabolites 1 Mol Ther Oncolytics 1 Nanomaterials (Basel) 1 Neurourol Urodyn 1 Oncogene 1 Oncol Lett 2 Oncologist 1 Pathol Res Pract 3 Pharmaceutics 1 PLoS One 1 Scand J Urol 1 Urol J 1 Vaccine 4 World J Urol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

APMIS

1. HYLDGAARD JM, Jensen JB
   The Inequality of Females in Bladder Cancer.
   APMIS. 2021 Sep 28. doi: 10.1111/apm.13183.
   PubMed         Abstract available
   
   

   
   Biomedicines

2. CANTO E, Faba OR, Zamora C, Mulet M, et al
   Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy.
   Biomedicines. 2021;9.
   PubMed         Abstract available
   
   

   
   Biomolecules

3. CAMPAGNA R, Pozzi V, Spinelli G, Sartini D, et al
   The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
   Biomolecules. 2021;11.
   PubMed         Abstract available
   
   

   
   BMC Urol

4. CHENG X, Zhou X, Yi M, Xu S, et al
   Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
   BMC Urol. 2021;21:136.
   PubMed         Abstract available
   
   

   
   BMJ Open

5. ARTHUSO FZ, Fairey AS, Boule NG, Courneya KS, et al
   Bladder cancer and exeRcise trAining during intraVesical thErapy-the BRAVE trial: a study protocol for a prospective, single-centre, phase II randomised controlled trial.
   BMJ Open. 2021;11:e055782.
   PubMed         Abstract available
   
   

   
   Br J Cancer

6. BARCLAY ME, Abel GA, Greenberg DC, Rous B, et al
   Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact.
   Br J Cancer. 2021 Feb 9. pii: 10.1038/s41416-021-01279.
   PubMed         Abstract available
   
   
7. TEO MY, Al-Ahmadie H, Seier K, Tully C, et al
   Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma.
   Br J Cancer. 2021;124:1214-1221.
   PubMed         Abstract available
   
   
8. SILVERS CR, Messing EM, Miyamoto H, Lee YF, et al
   Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer.
   Br J Cancer. 2021 Sep 25. pii: 10.1038/s41416-021-01554.
   PubMed         Abstract available
   
   

   
   Can Urol Assoc J

9. STRINGER L, Ly TL, Moreno NV, Hewitt C, et al
   Assessing geographic and industry-related trends in bladder cancer in Ontario: A population-based study.
   Can Urol Assoc J. 2021 Sep 24. pii: cuaj.7263. doi: 10.5489/cuaj.7263.
   PubMed         Abstract available
   
   

   
   Cancer Invest

10. ELUMALAI T, Periasamy K, Rajendran I, Yedala A, et al
    A Systematic Review of Radiation-Related Lymphopenia in Genito-urinary Malignancies.
    Cancer Invest. 2021;39:769-776.
    PubMed         Abstract available
    
    

    
    Cancer Radiother

11. OLLIVIER L, Guimas V, Rio E, Vaugier L, et al
    [Combination radiotherapy-immunotherapy in genitourinary cancer].
    Cancer Radiother. 2021;25.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

12. LEBLOND MM, Zdimerova H, Desponds E, Verdeil G, et al
    Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available
    
    
13. SUN K, Wang D, Yang BB, Ma J, et al
    The Emerging Functions of Circular RNAs in Bladder Cancer.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available
    
    
14. YOU C, Piao XM, Kang K, Kim YJ, et al
    Integrative Transcriptome Profiling Reveals SKA3 as a Novel Prognostic Marker in Non-Muscle Invasive Bladder Cancer.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available
    
    

    
    Cir Cir

15. REYES-ARROYO J, Mejia-Rios LC, Fernandez-Vivar E, Gutierrez-Quiroz CT, et al
    Urachal adenocarcinoma. Analysis of 8 years in a third level medical facility.
    Cir Cir. 2021;89:71-76.
    PubMed         Abstract available
    
    

    
    Clin Transl Med

16. CAO C, Yao L, Li A, Zhang Q, et al
    A CRISPR/dCasX-mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c-MYC or activating TP53.
    Clin Transl Med. 2021;11:e537.
    PubMed        
    
    

    
    Comput Biol Med

17. CHEONG JK, Popov V, Alchera E, Locatelli I, et al
    A numerical study to investigate the effects of tumour position on the treatment of bladder cancer in mice using gold nanorods assisted photothermal ablation.
    Comput Biol Med. 2021;138:104881.
    PubMed         Abstract available
    
    

    
    Cureus

18. YERGIN CG, Pafford R, Pirris J, Rao D, et al
    Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer.
    Cureus. 2021;13:e17446.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

19. BAART VM, van der Horst G, Deken MM, Bhairosingh SS, et al
    A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
    Eur J Cancer. 2021;146:11-20.
    PubMed         Abstract available
    
    

    
    Eur Urol Focus

20. ROUMIGUIE M, Black PC
    Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non-muscle-invasive bladder cancer: Pro.
    Eur Urol Focus. 2021 Sep 27. pii: S2405-4569(21)00234.
    PubMed         Abstract available
    
    

    
    Exp Ther Med

21. HE X, Xiao H, Yang R, Chen H, et al
    lncRNA LOC339524 inhibits the proliferation of bladder cancer cells by targeting the miR-875-5p/COPS7A signaling axis.
    Exp Ther Med. 2021;22:1202.
    PubMed         Abstract available
    
    
22. CHANG YH, Lin PH, Chen CC, Weng WH, et al
    Gain of TPPP as a predictor of progression in patients with bladder cancer.
    Exp Ther Med. 2021;22:1204.
    PubMed         Abstract available
    
    

    
    Front Cell Dev Biol

23. WANG F, Zhang Y, Zhou X, Chen X, et al
    Circular RNA CircPPP1CB Suppresses Tumorigenesis by Interacting With the MiR-1307-3p/SMG1 Axis in Human Bladder Cancer.
    Front Cell Dev Biol. 2021;9:704683.
    PubMed         Abstract available
    
    

    
    Front Genet

24. HE Y, Wu Y, Liu Z, Li B, et al
    Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer.
    Front Genet. 2021;12:694777.
    PubMed         Abstract available
    
    

    
    Front Oncol

25. FERRO M, Caputo VF, Barone B, Imbimbo C, et al
    Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
    Front Oncol. 2021;11:754649.
    PubMed        
    
    
26. WANG Y, Gao J, Hu S, Zeng W, et al
    SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism.
    Front Oncol. 2021;11:682710.
    PubMed         Abstract available
    
    

    
    Hum Exp Toxicol

27. ZHI Y, Sun F, Cai C, Li H, et al
    LINC00265 promotes the viability, proliferation, and migration of bladder cancer cells via the miR-4677-3p/FGF6 axis.
    Hum Exp Toxicol. 2021 Sep 30:9603271211043479. doi: 10.1177/09603271211043479.
    PubMed         Abstract available
    
    

    
    Int J Hyperthermia

28. BRUMMELHUIS ISG, Simons M, Lindner LH, Kort S, et al
    DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo.
    Int J Hyperthermia. 2021;38:1415-1424.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

29. TERAMOTO Y, Jiang G, Goto T, Mizushima T, et al
    Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

30. CHAN EO, Chan VW, Poon JY, Chan BH, et al
    Clear cell carcinoma of the urinary bladder: a systematic review.
    Int Urol Nephrol. 2021;53:815-824.
    PubMed         Abstract available
    
    

    
    J Basic Clin Physiol Pharmacol

31. CROCETTO F, Cimmino A, Ferro M, Terracciano D, et al
    Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine.
    J Basic Clin Physiol Pharmacol. 2021 Sep 27. pii: jbcpp-2021-0233.
    PubMed        
    
    

    
    J BUON

32. LI P, Yu Y, Wang X, Hu K, et al
    Biological functions of miR-363-3p/BTG2 in the metastasis of bladder cancer.
    J BUON. 2021;26:1498-1503.
    PubMed         Abstract available
    
    
33. LIU F, Wang N, Wei J, Xue M, et al
    Circ_0006948 drives the malignant development of bladder cancer via activating the epithelial-mesenchymal transition.
    J BUON. 2021;26:1491-1497.
    PubMed         Abstract available
    
    
34. GUAN Y, Zhang G, Li Z, Ai X, et al
    Diagnostic and prognostic potentials of AK126393 in bladder cancer.
    J BUON. 2021;26:1504-1508.
    PubMed         Abstract available
    
    

    
    J Clin Med

35. LEE J, Choo MS, Yoo S, Cho MC, et al
    Intravesical Prostatic Protrusion and Prognosis of Non-Muscle Invasive Bladder Cancer: Analysis of Long-Term Data over 5 Years with Machine-Learning Algorithms.
    J Clin Med. 2021;10.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

36. ITO Y, Ishida M, Ohe C, Miyasaka C, et al
    Signet-ring cell/histiocytoid carcinoma in the axilla: A case report with genetic analysis using next-generation sequencing.
    J Cutan Pathol. 2021;48:102-105.
    PubMed         Abstract available
    
    

    
    J Manag Care Spec Pharm

37. HEPP Z, Shah SN, Smoyer K, Vadagam P, et al
    Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis.
    J Manag Care Spec Pharm. 2021;27:240-255.
    PubMed         Abstract available
    
    

    
    J Med Case Rep

38. AKAN S, Ediz C
    A rare association in a patient with non-muscle invasive bladder cancer: ureteral fibroepithelial polyp and ipsilateral renal cell carcinoma: a case report.
    J Med Case Rep. 2021;15:475.
    PubMed         Abstract available
    
    

    
    J Pers Med

39. LI YR, Liu CH, Sun WC, Fan PY, et al
    The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone.
    J Pers Med. 2021;11.
    PubMed         Abstract available
    
    

    
    J Urol

40. KHANNA A, Zganjar A, Lyon T, Shah P, et al
    A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy.
    J Urol. 2021;206:970-977.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

41. LIU YH, Chou MH, Meng E, Kao CC, et al
    A Rare Case Report of Metastatic Urothelial Carcinoma to Skull with Significant Reossification after Pembrolizumab.
    Medicina (Kaunas). 2021;57.
    PubMed         Abstract available
    
    

    
    Metabolites

42. LEE S, Ku JY, Kang BJ, Kim KH, et al
    A Unique Urinary Metabolic Feature for the Determination of Bladder Cancer, Prostate Cancer, and Renal Cell Carcinoma.
    Metabolites. 2021;11.
    PubMed         Abstract available
    
    

    
    Mol Ther Oncolytics

43. KITAGAWA K, Tatsumi M, Kato M, Komai S, et al
    An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model.
    Mol Ther Oncolytics. 2021;22:592-603.
    PubMed         Abstract available
    
    

    
    Nanomaterials (Basel)

44. GOMEZ BB, Lopez-Cortes R, Casas-Nebra FJ, Vazquez-Estevez S, et al
    Detection of Circulating Serum Protein Biomarkers of Non-Muscle Invasive Bladder Cancer after Protein Corona-Silver Nanoparticles Analysis by SWATH-MS.
    Nanomaterials (Basel). 2021;11.
    PubMed         Abstract available
    
    

    
    Neurourol Urodyn

45. VOLZ Y, Eismann L, Pfitzinger PL, Jokisch JF, et al
    Salvage cystectomy and ileal conduit urinary diversion as a last-line option for benign diseases-perioperative safety and postoperative health-related quality of life.
    Neurourol Urodyn. 2021;40:1154-1164.
    PubMed         Abstract available
    
    

    
    Oncogene

46. CHEN X, Chen H, Yao H, Zhao K, et al
    Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer.
    Oncogene. 2021 Sep 29. pii: 10.1038/s41388-021-02024.
    PubMed         Abstract available
    
    

    
    Oncol Lett

47. YIN Y, Fan Y, Yu G, Du Y, et al
    LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion.
    Oncol Lett. 2021;22:765.
    PubMed         Abstract available
    
    

    
    Oncologist

48. YANG K, Yu W, Liu H, Ding F, et al
    Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Oncologist. 2021;26:e1395-e1405.
    PubMed         Abstract available
    
    
49. LAVOIE JM, Sridhar SS, Ong M, North S, et al
    The Rapidly Evolving Landscape of First-Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review.
    Oncologist. 2021;26:e1381-e1394.
    PubMed         Abstract available
    
    

    
    Pathol Res Pract

50. YU K, Liu M, Huang Y, Yu Q, et al
    circMBOAT2 serves as the sponge of miR-433-3p to promote the progression of bladder cancer.
    Pathol Res Pract. 2021;227:153613.
    PubMed         Abstract available
    
    

    
    Pharmaceutics

51. MENILLI L, Monteiro AR, Lazzarotto S, Morais FMP, et al
    Graphene Oxide and Graphene Quantum Dots as Delivery Systems of Cationic Porphyrins: Photo-Antiproliferative Activity Evaluation towards T24 Human Bladder Cancer Cells.
    Pharmaceutics. 2021;13.
    PubMed         Abstract available
    
    
52. MANAN FAA, Yusof NA, Abdullah J, Mohammad F, et al
    Drug Release Profiles of Mitomycin C Encapsulated Quantum Dots-Chitosan Nanocarrier System for the Possible Treatment of Non-Muscle Invasive Bladder Cancer.
    Pharmaceutics. 2021;13.
    PubMed         Abstract available
    
    
53. CHEN S, Deng C, Zheng W, Li S, et al
    Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment.
    Pharmaceutics. 2021;13.
    PubMed         Abstract available
    
    

    
    PLoS One

54. KLOSE K, Packeiser EM, Muller P, Granados-Soler JL, et al
    Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.
    PLoS One. 2021;16:e0257403.
    PubMed         Abstract available
    
    

    
    Scand J Urol

55. TENNINGE S, Mogos H, Eriksson E, Netterling H, et al
    Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status.
    Scand J Urol. 2021 Sep 30:1-6. doi: 10.1080/21681805.2021.1981996.
    PubMed         Abstract available
    
    

    
    Urol J

56. DONG Y, Zhang T, Li X, Yu F, et al
    Urine Biomarkers for the Diagnosis of Bladder Cancer: a Network Meta-Analysis.
    Urol J. 2021 Sep 29. pii: 6254. doi: 10.22037/uj.v18i.6254.
    PubMed         Abstract available
    
    

    
    Vaccine

57. SINGH AK, Srikrishna G, Bivalacqua TJ, Bishai WR, et al
    Recombinant BCGs for tuberculosis and bladder cancer.
    Vaccine. 2021 Sep 27. pii: S0264-410X(21)01231.
    PubMed         Abstract available
    
    

    
    World J Urol

58. MAGISTRO G, Zimmermann L, Bischoff R, Westhofen T, et al
    The natural course of urinalysis after urinary diversion.
    World J Urol. 2021;39:1559-1567.
    PubMed         Abstract available
    
    
59. VAN HOOGSTRATEN LMC, van Gennep EJ, Kiemeney LALM, Witjes JA, et al
    Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients.
    World J Urol. 2021 Sep 28. pii: 10.1007/s00345-021-03839.
    PubMed         Abstract available
    
    
60. TOREN P, Brisson H, Simonyan D, Hovington H, et al
    Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.
    World J Urol. 2021;39:1549-1558.
    PubMed         Abstract available
    
    
61. CHENG KW, Yip W, Shah A, Medina LG, et al
    Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions.
    World J Urol. 2021;39:1521-1529.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: